Patient Care

Inflammatory Cytokine Levels “Increased in Atrial Fibrillation After CAR T Therapy

01.05.23

Inflammatory Cytokine Levels “Increased in Atrial Fibrillation After CAR T Therapy

by Eleanor Mayfield, ELS

Adoptive immunotherapy for AML using CAR.CD123-NK cells

12.22.22

Adoptive immunotherapy for AML using CAR.CD123-NK cells

by ASTCT Science Highlights

CRISPR-Cas9 Gene Editing Used to Refine Allogeneic CAR T Cells

12.21.22

CRISPR-Cas9 Gene Editing Used to Refine Allogeneic CAR T Cells

by Eleanor Mayfield, ELS

aaTPs enable development of standardized in-vitro assays for CAR-T cells

12.20.22

aaTPs enable development of standardized in-vitro assays for CAR-T cells

by ASTCT Science Highlights

FOLR1 a target for CAR T therapy in C/G model of pediatric AML

11.24.22

FOLR1 a target for CAR T therapy in C/G model of pediatric AML

by ASTCT Science Highlights

Study Finds Lower Rates of CAR T Adverse Effects in Real-Word Settings Than in Clinical Trials

11.22.22

Study Finds Lower Rates of CAR T Adverse Effects in Real-Word Settings Than in Clinical Trials

by Eleanor Mayfield, ELS

“No Long-Term QOL Detriment” Due to CRS or NEs in TRANSCEND Trial

11.22.22

“No Long-Term QOL Detriment” Due to CRS or NEs in TRANSCEND Trial

by Eleanor Mayfield, ELS

Integration of Allogeneic CAR-T and HCT using PTCy in murine model

11.15.22

Integration of Allogeneic CAR-T and HCT using PTCy in murine model

by ASTCT Science Highlights

PRAME mTCRCAR T cell therapy in AML

10.27.22

PRAME mTCRCAR T cell therapy in AML

by ASTCT Science Highlights

THANK YOU TO OUR SPONSORS

Jansen Oncology

Legend Biotech